The Year in Cardiovascular Surgery

Journal of the American College of Cardiology

Volumn 53, Issue 25, 2009, Pages 2389-2403

  Adams, David H ^a   Anyanwu, Anelechi C ^a   Chikwe, Joanna ^a   Filsoufi, Farzan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular surgery; coronary bypass surgery; heart failure surgery; valve surgery

Indexed keywords

AMINOCAPROIC ACID; APROTININ; ATORVASTATIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ANEMIA; ANEURYSM; ANNULOPLASTY; AORTA STENOSIS; AORTA SURGERY; AORTA VALVE; AORTIC VALVE REPAIR; ARTERY GRAFT; ASSISTED CIRCULATION; BICUSPID AORTIC VALVE; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGERY; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; DRUG ELUTING STENT; GRAFT PATENCY; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEART VALVE REPLACEMENT; HEART VENTRICLE REMODELING; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPLANTATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEDICARE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; MYOBLAST; OBESITY; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; VALVULAR HEART DISEASE; VASCULAR SURGERY; VEIN GRAFT DISEASE;

AORTA; BLOOD TRANSFUSION; CARDIOVASCULAR SURGICAL PROCEDURES; HEART DISEASES; HUMANS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 66949160666     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.02.061     Document Type: Review

References (46)

1. Magne J., Senechal M., Mathieu P., Dumesnil J.G., Dagenais F., and Pibarot P. Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 51 (2008) 1692-1701
2. Braun J., van de Veire N.R., Klautz R.J., et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 85 (2008) 430-436 discussion 436-7
3. Russo A., Grigioni F., Avierinos J.F., et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J Am Coll Cardiol 51 (2008) 1203-1211
4. Dion R.A. Thromboembolic complications after surgical correction of mitral regurgitation finding a balance. J Am Coll Cardiol 51 (2008) 1212-1213
5. Suri R.M., Schaff H.V., Dearani J.A., et al. Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation. J Thorac Cardiovasc Surg 136 (2008) 442-447
6. Flameng W., Meuris B., Herijgers P., and Herregods M.C. Durability of mitral valve repair in Barlow disease versus fibroelastic deficiency. J Thorac Cardiovasc Surg 135 (2008) 274-282
7. Adams D.H., and Anyanwu A.C. The cardiologist's role in increasing the rate of mitral valve repair in degenerative disease. Curr Opin Cardiol 23 (2008) 105-110
8. Adams D.H., and Anyanwu A.C. Seeking a higher standard for degenerative mitral valve repair: begin with etiology. J Thorac Cardiovasc Surg 136 (2008) 551-556
9. Levy F., Laurent M., Monin J.L., et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol 51 (2008) 1466-1472
10. Dewey T.M., Brown D.L., Das T.S., et al. High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg 86 (2008) 1450-1456 discussion 1456-7
11. Grube E., Buellesfeld L., Mueller R., et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve revalving system. Circ Cardiovasc Intervent 1 (2008) 167-175
12. Svensson L.G., Dewey T., Kapadia S., et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 86 (2008) 46-54 discussion 54-5
13. Walther T., Falk V., Kempfert J., et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 33 (2008) 983-988
14. Pettersson G.B., Crucean A.C., Savage R., et al. Toward predictable repair of regurgitant aortic valves: a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol 52 (2008) 40-49
15. Borer J.S., and Girardi L.N. Repair of the congenitally bicuspid regurgitant aortic valve: a strategic advance. J Am Coll Cardiol 52 (2008) 50-51
16. Buszman P.E., Kiesz S.R., Bochenek A., et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 51 (2008) 538-545
17. Seung K.B., Park D.W., Kim Y.H., et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358 (2008) 1781-1792
18. Taggart D.P., Kaul S., Boden W.E., et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol 51 (2008) 885-892
19. Shemin R.J. Coronary artery bypass grafting versus stenting for unprotected left main coronary artery disease: where lies the body of proof?. Circulation 118 (2008) 2326-2329
20. Hannan E.L., Wu C., Walford G., et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358 (2008) 331-341
21. Carrozza Jr. J.P. Drug-eluting stents-pushing the envelope beyond the labels?. N Engl J Med 358 (2008) 405-407
22. Goy J.J., Kaufmann U., Hurni M., et al. 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA (Stenting Versus Internal Mammary Artery Grafting) trial. J Am Coll Cardiol 52 (2008) 815-817
23. Shah S.J., Waters D.D., Barter P., et al. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol 51 (2008) 1938-1943
24. Wee C.C., Girotra S., Weinstein A.R., Mittleman M.A., and Mukamal K.J. The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy. J Am Coll Cardiol 52 (2008) 620-625
25. Halkos M.E., Puskas J.D., Lattouf O.M., et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 136 (2008) 631-640
26. Magee M.J., Alexander J.H., Hafley G., et al. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. Ann Thorac Surg 85 (2008) 494-499 discussion 499-500
27. Hernandez A.F., Shea A.M., Milano C.A., et al. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA 300 (2008) 2398-2406
28. John R., Kamdar F., Liao K., Colvin-Adams M., Boyle A., and Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 86 (2008) 1227-1234 discussion 1234-5
29. Long J.W., Healy A.H., Rasmusson B.Y., et al. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg 135 (2008) 1353-1360 discussion 1360-1
30. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
31. Mehta R.H., Grab J.D., O'Brien S.M., et al. Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from The Society of Thoracic Surgeons National Cardiac Database. Circulation 117 (2008) 876-885
32. Goland S., Czer L.S., Kass R.M., et al. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am Coll Cardiol 51 (2008) 1214-1220
33. Brieke A., Krishnamani R., Rocha M.J., et al. Influence of donor cocaine use on outcome after cardiac transplantation: analysis of the United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 27 (2008) 1350-1352
34. Makaroun M.S., Dillavou E.D., Wheatley G.H., and Cambria R.P. Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg 47 (2008) 912-918
35. Greenberg R.K., Lu Q., Roselli E.E., et al. Contemporary analysis of descending thoracic and thoracoabdominal aneurysm repair: a comparison of endovascular and open techniques. Circulation 118 (2008) 808-817
36. Melo J., Santiago T., Aguiar C., et al. Surgery for atrial fibrillation in patients with mitral valve disease: results at five years from the International Registry of Atrial Fibrillation Surgery. J Thorac Cardiovasc Surg 135 (2008) 863-869
37. Mariscalco G., Klersy C., Zanobini M., et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation 118 (2008) 1612-1618
38. Kanderian A.S., Gillinov A.M., Pettersson G.B., Blackstone E., and Klein A.L. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 52 (2008) 924-929
39. Salzberg S.P., Gillinov A.M., Anyanwu A., Castillo J., Filsoufi F., and Adams D.H. Surgical left atrial appendage occlusion: evaluation of a novel device with magnetic resonance imaging. Eur J Cardiothorac Surg 34 (2008) 766-770
40. Chitwood Jr. W.R., Rodriguez E., Chu M.W., et al. Robotic mitral valve repairs in 300 patients: a single-center experience. J Thorac Cardiovasc Surg 136 (2008) 436-441
41. Koch C.G., Li L., Sessler D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 (2008) 1229-1239
42. Karkouti K., Wijeysundera D.N., and Beattie W.S. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 117 (2008) 478-484
43. Shaw A.D., Stafford-Smith M., White W.D., et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med 358 (2008) 784-793
44. Schneeweiss S., Seeger J.D., Landon J., et al. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 358 (2008) 771-783
45. Fergusson D.A., Hebert P.C., Mazer C.D., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
46. Sundt T.M. The demise of aprotinin: our share of the blame. J Thorac Cardiovasc Surg 135 (2008) 729-731